Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Holmström M[au]:

Search results

Items: 1 to 50 of 236

1.

Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis.

Helal CJ, Bundesmann M, Hammond S, Holmstrom M, Klug-McLeod J, Lefker BA, McLeod D, Subramanyam C, Zakaryants O, Sakata S.

ACS Med Chem Lett. 2019 Jul 5;10(8):1104-1109. doi: 10.1021/acsmedchemlett.9b00205. eCollection 2019 Aug 8.

PMID:
31413793
2.

Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years.

Osooli M, Donfield SM, Carlsson KS, Baghaei F, Holmström M, Berntorp E, Astermark J.

Haemophilia. 2019 Aug 14. doi: 10.1111/hae.13831. [Epub ahead of print]

PMID:
31411798
3.

Hypertension and cardiovascular diseases in Swedish persons with haemophilia - A longitudinal registry study.

Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Berntorp E, Astermark J.

Thromb Res. 2019 Jul 21;181:106-111. doi: 10.1016/j.thromres.2019.07.017. [Epub ahead of print]

PMID:
31386935
4.

B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment.

Sørensen AL, Bjørn ME, Riley CH, Holmstrøm M, Andersen MH, Svane IM, Mikkelsen SU, Skov V, Kjaer L, Hasselbalch HC, Nielsen CH.

Eur J Haematol. 2019 Jul 11. doi: 10.1111/ejh.13292. [Epub ahead of print]

PMID:
31297883
5.

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy.

Holmström MO, Novotny GW, Petersen J, Aaboe-Jørgensen M, Hasselbalch HC, Andersen MH, Nielsen SL, Fassi DE, Schöllkopf C.

Leuk Lymphoma. 2019 Jul 1:1-4. doi: 10.1080/10428194.2019.1633634. [Epub ahead of print] No abstract available.

PMID:
31256699
6.

Neo-antigen specific memory T-cell responses in healthy individuals.

Holmström MO, Hasselbalch HC, Andersen MH.

Oncoimmunology. 2019 Apr 19;8(7):1599640. doi: 10.1080/2162402X.2019.1599640. eCollection 2019.

PMID:
31143522
7.

Incident Chronic Rhinosinusitis Is Associated With Impaired Sleep Quality: Results of the RHINE Study.

Bengtsson C, Jonsson L, Holmström M, Hellgren J, Franklin K, Gíslason T, Holm M, Johannessen A, Jõgi R, Schlünssen V, Janson C, Lindberg E.

J Clin Sleep Med. 2019 Jun 15;15(6):899-905. doi: 10.5664/jcsm.7846.

PMID:
31138385
8.

The Largest Electron Differential Energy Flux Observed at Mars by the Mars Express Spacecraft, 2004-2016.

Frahm RA, Winningham JD, Coates AJ, Gérard JC, Holmström M, Barabash S.

J Geophys Res Space Phys. 2018 Aug;123(8):6576-6590. doi: 10.1029/2018JA025311. Epub 2018 Aug 22.

9.

The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.

Bjermer L, Westman M, Holmström M, Wickman MC.

Allergy Asthma Clin Immunol. 2019 Apr 16;15:24. doi: 10.1186/s13223-018-0314-1. eCollection 2019. Review.

10.

Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients.

Schmidt DE, Chaireti R, Bruzelius M, Holmström M, Antovic J, Ågren A.

Thromb Res. 2019 Jun;178:34-40. doi: 10.1016/j.thromres.2019.03.022. Epub 2019 Apr 1.

PMID:
30959280
11.

[Cancer immune therapy for the treatment of haematological malignancies].

Holmström MO, Klausen U, Jørgensen NG, Holmberg S, Grauslund J, Met Ö, Svane IM, Pedersen LM, Knudsen LM, Hasselbalch HC, Andersen MH.

Ugeskr Laeger. 2019 Mar 4;181(10). pii: V06180421. Danish.

PMID:
30869069
12.

Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.

Lehmonen L, Kaasalainen T, Atula S, Mustonen T, Holmström M.

Int J Cardiovasc Imaging. 2019 Feb;35(2):351-358. doi: 10.1007/s10554-019-01570-4. Epub 2019 Mar 8.

13.

Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population.

Vuorinen AM, Pakarinen S, Jaakkola I, Holmström M, Kivistö S, Kaasalainen T.

Acta Radiol. 2019 Feb 19:284185119830288. doi: 10.1177/0284185119830288. [Epub ahead of print]

PMID:
30781967
14.

Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis.

Versloot O, Berntorp E, Petrini P, Ljung R, Astermark J, Holmström M, de Kleijn P, Fischer K.

Haemophilia. 2019 Mar;25(2):244-251. doi: 10.1111/hae.13683. Epub 2019 Jan 28.

PMID:
30690833
15.

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals.

Holmström MO, Ahmad SM, Klausen U, Bendtsen SK, Martinenaite E, Riley CH, Svane IM, Kjær L, Skov V, Ellervik C, Pallisgaard N, Hasselbalch HC, Andersen MH.

Blood Cancer J. 2019 Jan 17;9(2):8. doi: 10.1038/s41408-018-0166-4.

16.

Blood inflammatory and endothelial markers in women with von Willebrand disease.

Govorov I, Bremme K, Larsson A, Holmström M, Komlichenko E, Chaireti R, Mints M.

PLoS One. 2019 Jan 10;14(1):e0210544. doi: 10.1371/journal.pone.0210544. eCollection 2019.

17.

Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.

Govorov I, Bremme K, Lindahl TL, Holmström M, Komlichenko E, Chaireti R, Mints M.

Sci Rep. 2018 Nov 30;8(1):17467. doi: 10.1038/s41598-018-35897-0.

18.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.

Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.

Leukemia. 2019 Apr;33(4):995-1010. doi: 10.1038/s41375-018-0295-6. Epub 2018 Nov 23.

PMID:
30470838
19.

[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs].

Hjemdahl P, Braunschweig F, Holmström M, Johnsson H, von Euler M, Wallén H, Forslund T.

Lakartidningen. 2018 Oct 26;115. pii: FAH6. Review. Swedish.

20.

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.

Klausen U, Holmberg S, Holmström MO, Jørgensen NGD, Grauslund JH, Svane IM, Andersen MH.

Front Immunol. 2018 Oct 1;9:2264. doi: 10.3389/fimmu.2018.02264. eCollection 2018. Review.

21.

Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation.

Jørgensen MA, Holmström MO, Martinenaite E, Riley CH, Hasselbalch HC, Andersen MH.

Oncoimmunology. 2018 Jul 23;7(9):e1468957. doi: 10.1080/2162402X.2018.1468957. eCollection 2018.

22.

A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).

He S, Eelde A, Petrini P, Wallen H, Gabrielsson L, Svensson J, Blombäck M, Holmström M.

Thromb Res. 2018 Nov;171:7-13. doi: 10.1016/j.thromres.2018.09.041. Epub 2018 Sep 5.

PMID:
30216822
23.

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

Hasselbalch HC, Holmström MO.

Semin Immunopathol. 2019 Jan;41(1):5-19. doi: 10.1007/s00281-018-0700-2. Epub 2018 Sep 10. Review.

24.

Being Facilitators in a Challenging Context-School Personnel's Experiences of Caring for Youth with Diabetes Type 1.

Holmström MR, Häggström M, Söderberg S.

J Pediatr Nurs. 2018 Nov - Dec;43:e114-e119. doi: 10.1016/j.pedn.2018.08.007. Epub 2018 Aug 10.

25.

Nurses' experiences of prehospital care encounters with children in pain.

Holmström MR, Junehag L, Velander S, Lundberg S, Ek B, Häggström M.

Int Emerg Nurs. 2019 Mar;43:23-28. doi: 10.1016/j.ienj.2018.07.004. Epub 2018 Jul 20.

PMID:
30037542
26.

Cancer immune therapy for lymphoid malignancies: recent advances.

Klausen U, Jørgensen NGD, Grauslund JH, Holmström MO, Andersen MH.

Semin Immunopathol. 2019 Jan;41(1):111-124. doi: 10.1007/s00281-018-0696-7. Epub 2018 Jul 13. Review.

PMID:
30006739
27.

Cancer immune therapy for myeloid malignancies: present and future.

Holmström MO, Hasselbalch HC.

Semin Immunopathol. 2019 Jan;41(1):97-109. doi: 10.1007/s00281-018-0693-x. Epub 2018 Jul 9. Review.

PMID:
29987478
28.

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response.

Holmström MO, Riley CH, Skov V, Svane IM, Hasselbalch HC, Andersen MH.

Oncoimmunology. 2018 Feb 27;7(6):e1433521. doi: 10.1080/2162402X.2018.1433521. eCollection 2018.

29.

Voice Quality in Adults Treated for Unilateral Cleft Lip and Palate: Long-Term Follow-Up After One- or Two-Stage Palate Repair.

Morén S, Lindestad PÅ, Holmström M, Mani M.

Cleft Palate Craniofac J. 2018 Sep;55(8):1103-1114. doi: 10.1177/1055665618764521. Epub 2018 Mar 21.

PMID:
29561718
30.

Age-adjusted D-dimer cut-off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays.

Farm M, Siddiqui AJ, Onelöv L, Järnberg I, Eintrei J, Maskovic F, Kallner A, Holmström M, Antovic JP.

J Thromb Haemost. 2018 May;16(5):866-875. doi: 10.1111/jth.13994. Epub 2018 Apr 17.

PMID:
29505695
31.

Voice Quality in Adults Treated for Unilateral Cleft Lip and Palate: Long-term Follow-up After 1- or 2-Stage Palate Repair.

Morén S, Lindestad PÅ, Holmström M, Mani M.

Cleft Palate Craniofac J. 2018 May;55(5):758-768. doi: 10.1177/1055665618754946. Epub 2018 Feb 20.

PMID:
29461876
32.

Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction - a prospective CMR study.

Pöyhönen P, Kylmälä M, Vesterinen P, Kivistö S, Holmström M, Lauerma K, Väänänen H, Toivonen L, Hänninen H.

BMC Cardiovasc Disord. 2018 Feb 8;18(1):27. doi: 10.1186/s12872-018-0767-7.

33.

The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.

Ahmad SM, Martinenaite E, Holmström M, Jørgensen MA, Met Ö, Nastasi C, Klausen U, Donia M, Pedersen LM, Munksgaard L, Ødum N, Woetmann A, Svane IM, Andersen MH.

Oncoimmunology. 2017 Nov 1;7(2):e1390641. doi: 10.1080/2162402X.2017.1390641. eCollection 2018.

34.

Epicardial delivery of autologous atrial appendage micrografts during coronary artery bypass surgery-safety and feasibility study.

Nummi A, Nieminen T, Pätilä T, Lampinen M, Lehtinen ML, Kivistö S, Holmström M, Wilkman E, Teittinen K, Laine M, Sinisalo J, Kupari M, Kankuri E, Juvonen T, Vento A, Suojaranta R, Harjula A; AADC consortium.

Pilot Feasibility Stud. 2017 Dec 20;3:74. doi: 10.1186/s40814-017-0217-9. eCollection 2017.

35.

One-Year Follow-up Study Detects Myocardial Changes with Cardiovascular Magnetic Resonance Tagging in Active Rheumatoid Arthritis.

Lehmonen L, Vuorinen AM, Koivuniemi R, Leirisalo-Repo M, Holmström M, Kivistö S, Kaasalainen T.

Acad Radiol. 2018 Apr;25(4):476-485. doi: 10.1016/j.acra.2017.10.017. Epub 2017 Dec 1.

PMID:
29199058
36.

Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP.

Ljungkvist M, Berndtsson M, Holmström M, Mikovic D, Elezovic I, Antovic JP, Zetterberg E, Berntorp E.

Mediterr J Hematol Infect Dis. 2017 Nov 1;9(1):e2017064. doi: 10.4084/MJHID.2017.064. eCollection 2017.

37.

The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy.

Holmström MO, Hasselbalch HC, Andersen MH.

Oncoimmunology. 2017 Aug 2;6(11):e1358334. doi: 10.1080/2162402X.2017.1358334. eCollection 2017.

38.

Additional mechanism for left ventricular dysfunction: chronic pulmonary regurgitation decreases left ventricular preload in patients with tetralogy of Fallot.

Ylitalo P, Jokinen E, Lauerma K, Holmström M, Pitkänen-Argillander OM.

Cardiol Young. 2018 Feb;28(2):208-213. doi: 10.1017/S1047951117001457. Epub 2017 Oct 11.

PMID:
29019299
39.

Long-term quality of life and postthrombotic syndrome in women after an episode of venous thromboembolism.

Ljungqvist M, Holmström M, Kieler H, Lärfars G.

Phlebology. 2018 May;33(4):234-241. doi: 10.1177/0268355517698620. Epub 2017 Mar 16.

PMID:
28956493
40.

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study.

Majeed A, Ågren A, Holmström M, Bruzelius M, Chaireti R, Odeberg J, Hempel EL, Magnusson M, Frisk T, Schulman S.

Blood. 2017 Oct 12;130(15):1706-1712. doi: 10.1182/blood-2017-05-782060. Epub 2017 Aug 23.

41.

Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.

Qadri S, Anttonen O, Viikilä J, Seppälä EH, Myllykangas S, Alastalo TP, Holmström M, Heliö T, Koskenvuo JW.

BMC Med Genet. 2017 Aug 17;18(1):86. doi: 10.1186/s12881-017-0442-3.

42.

Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes.

Kjaer L, Holmström MO, Cordua S, Andersen MH, Svane IM, Thomassen M, Kruse TA, Pallisgaard N, Skov V, Hasselbalch HC.

Leuk Lymphoma. 2018 Apr;59(4):973-977. doi: 10.1080/10428194.2017.1359743. Epub 2017 Aug 9. No abstract available.

PMID:
28792253
43.

Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease.

Schmidt DE, Bruzelius M, Majeed A, Odeberg J, Holmström M, Ågren A.

Thromb Haemost. 2017 Jul 26;117(8):1528-1533. doi: 10.1160/TH17-02-0129. Epub 2017 Jul 6.

PMID:
28692107
44.

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

Holmström MO, Martinenaite E, Ahmad SM, Met Ö, Friese C, Kjær L, Riley CH, Thor Straten P, Svane IM, Hasselbalch HC, Andersen MH.

Leukemia. 2018 Feb;32(2):429-437. doi: 10.1038/leu.2017.214. Epub 2017 Jul 5.

PMID:
28676668
45.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A.

Thromb Res. 2017 Oct;158:168-173. doi: 10.1016/j.thromres.2017.06.028. Epub 2017 Jun 24.

PMID:
28669410
46.

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.

Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E.

Haemophilia. 2017 May;23(3):e180-e187. doi: 10.1111/hae.13231. Epub 2017 Apr 10.

PMID:
28393468
47.

Mortality caused by intracranial bleeding in non-severe hemophilia A patients.

Loomans JI, Eckhardt CL, Reitter-Pfoertner SE, Holmström M, van Gorkom BL, Leebeek FWG, Santoro C, Haya S, Meijer K, Nijziel MR, van der Bom JG, Fijnvandraat K.

J Thromb Haemost. 2017 Jun;15(6):1115-1122. doi: 10.1111/jth.13693. Epub 2017 May 4.

48.

Chronic Rhinosinusitis Impairs Sleep Quality: Results of the GA2LEN Study.

Bengtsson C, Lindberg E, Jonsson L, Holmström M, Sundbom F, Hedner J, Malinovschi A, Middelveld R, Forsberg B, Janson C.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw021.

PMID:
28364469
49.

Can objective measurements of the nasal form and function represent the clinical picture in unilateral cleft lip and palate?

Peroz R, Holmström M, Mani M.

J Plast Reconstr Aesthet Surg. 2017 May;70(5):653-658. doi: 10.1016/j.bjps.2017.01.024. Epub 2017 Feb 27.

PMID:
28325563
50.

Respiratory symptoms and lung function in relation to wood dust and monoterpene exposure in the wood pellet industry.

Löfstedt H, Hagström K, Bryngelsson IL, Holmström M, Rask-Andersen A.

Ups J Med Sci. 2017 Jun;122(2):78-84. doi: 10.1080/03009734.2017.1285836. Epub 2017 Mar 1.

Supplemental Content

Loading ...
Support Center